1. Introduction {#s0005}
===============

The ribosome inactivating proteins (RIPs) are N-glycosidases which are known to remove the specific purine residues from the sarcin/ricin (S/R) loop of the large rRNA [@bib1], [@bib2]. This leads to the inhibition of protein synthesis in the cell [@bib3]. The X-ray crystallographic studies have shown that RIPs bind specifically to adenine base [@bib4]. A number of structures of type 1 RIPs from different sources in native forms [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15] as well as of its several complexes with various ligands are already known [@bib3], [@bib12], [@bib13]. The type 1 RIPs catalyze the removal of adenine residue from the sarcin/ricin loop (SRL) of rRNA in eukaryotic ribosomes [@bib2], [@bib3]. These RIPs have also been shown to recognize the mRNA 5' cap structures with m^7^GpppN motif where N is any base [@bib12]. There are several reports about interactions of RIPs with purine bases of RNA such as adenine and guanine but no structural information is available on the mode of binding of pyrimidine bases such as cytosine and thymine. Therefore, it will be of interest to examine the modes of binding of pyrimidine bases to a type 1 RIP. We report here the binding studies of a type 1 RIP from *Momordica balsamina* (*Mb*RIP1) with three compounds, (i) cytosine (CYS), (ii) cytidine (CYT), and (iii) cytidine diphosphate (CDP). All three compounds bound to *Mb*RIP1 at the active site with dissociation constants of 10^−4^ M--10^−7^ M. The orientation of cytosine in the substrate binding cleft is found to be different from that of adenine and guanine in the complexes of *Mb*RIP1 with adenine and guanine [@bib13].

2. Materials and methods {#s0010}
========================

2.1. Isolation and purification {#s0015}
-------------------------------

The purification of *Mb*RIP1 was carried out using the protocol reported earlier [@bib13]. The samples of purified protein were concentrated using Amicon ultrafiltration device (Millipore Corporation, Bedford, USA) with a membrane having a molecular weight cut off of 3 kDa.

2.2. Binding studies using fluorescence {#s0020}
---------------------------------------

The binding studies of *Mb*RIP1 with compounds (i) CYS, (ii) CYT and (iii) CDP were carried out with spectrofluorometer FP -6200 (Shimadzu, Kyoto, Japan). 2.5 mg of protein was dissolved in 25 mM of sodium phosphate buffer at pH 6.8 at a concentration of 1×10^−8^ M. This solution was loaded in the 1 cm quartz cuvette. The stock solutions of CYS, CYT and CDP were also prepared in 25 mM sodium phosphate buffer pH 6.8 at concentrations of 1 mM. The concentration of all the three ligands were varied by adding increasing volumes of 1 µM, 2 µM, 5 µM, 10 µM, and 20 µM of CYS, CYT and CDP respectively from their stock solutions made at a concentration of 1 mM. The fluorescence experiments were conducted under the conditions of both entrance and exit slit widths at 5 nm and scanning speed of 240 nm/min. The fluorescence spectra of protein were recorded in the range of 300--400 nm at an excitation of 280 nm at 298 K ([Fig. 1](#f0005){ref-type="fig"}). All the observations were repeated six times for estimating the experimental errors. The spectral changes of the protein were recorded with different ligands at various concentrations.Fig. 1Binding curves for cytosine (-●-), cytidine (-○-), and cytidine diphosphate (-▼-) showing the changes in fluorescence intensities (Δ*F*/*F*~o~) at 280 nm as the three compounds bound to *Mb*RIP1 with increasing molar concentrations of ligands. The errors on the experimental points have been indicated.Fig. 1

2.3. Binding studies using surface plasmon resonance spectroscopy {#s0025}
-----------------------------------------------------------------

The surface plasmon resonance (SPR) measurements were carried out using Biacore-2000 (Pharmacia Biosensor AB, Uppsala, Sweden) at 25 °C in which a biosensor based system has been used for real time specific interaction analysis. The sensor chip CM5, surfactant P20, the amine coupling kit containing N-hydroxyl succinimide (NHS), N-ethyl-N'-3(diethyl amino propyl) carbamide (EDC) and ethanolamine hydrochloride (Pharmacia Biosensor AB, Uppsala, Sweden) were used in the experiment. The immobilization of *Mb*RIP1 was performed at a flow rate of 10 μl/min using amine coupling kit. The dextran on the chip was equilibrated with running buffer and carboxy methylated matrix was activated with EDC/NHS mixture and 200 μl of *Mb*RIP1 (200 μg/ml) in 10 mM sodium acetate at pH 5.0, the unreacted groups were blocked by injecting ethanolamine (pH 8.5). The SPR signal for immobilized *Mb*RIP1 reached 14357.8 RUs. Three concentrations of analytes, 1.0 μM, 2.0 μM and 4.0 μM were passed over immobilized *Mb*RIP1 at a flow rate of 10 μl/min. The regeneration of protein surface from bound analyte was done using 10 mM glycine HCl at pH 3.0 ([Fig. 2](#f0010){ref-type="fig"}). The association (*K*~on~) and dissociation (*K*~off~) rate constants for the analytes bindings to *Mb*RIP1 were calculated and the values of dissociation constants (*K*~D~) were determined by mass action relation *K*~D~=*K*~off~/ *K*~on~ using BIAevaluation 3.0 software provided by the manufacturer.Fig. 2Sensogram for the binding of analytes, (A) cytosine, (B) cytidine, and (C) cytidine diphosphate to *Mb*RIP1. The protein was immobilized on CM-5 chip and increasing concentrations (1 mM, 2 mM and 4 mM) of analytes were used in mobile phase corresponding to curves a, b and c respectively.Fig. 2

2.4. Crystallization {#s0030}
--------------------

The freshly purified and lyophilized samples of *Mb*RIP1 were dissolved in 25 mM sodium phosphate buffer at pH 6.8 to a concentration of 20 mg/ml. CYS, CYT and CDP were also dissolved separately in the same buffer. The solutions of ligands were mixed separately with the protein solution in 1:1 (v/v) ratios and were incubated overnight at room temperature (\~295 K). A solution containing 0.1 M sodium phosphate buffer pH 6.8 and 16% (v/v) polyethylene glycol 6000 (PEG-6000) was prepared as the reservoir buffer for the purpose of crystallization. It was mixed with each of the incubated solutions containing protein and ligand in 1:1 (v/v) ratio. The 6 µl drops of these solutions were prepared for the hanging drop vapor diffusion method at 298 K. After 10 days, cuboid shaped crystals from all the three sets of experiments were obtained.

2.5. X-ray intensity data collection and processing {#s0035}
---------------------------------------------------

Three X-ray intensity data sets were collected using one crystal each from the three samples containing complexes of *Mb*RIP1 with (i) CYS, (ii) CYT, and (iii) CDP. The crystals were mounted in nylon loops and frozen in liquid nitrogen stream at 100 K. For data collection MAR CCD scanner (MAR Research, Norderstedt, Germany) was used on the BM14 Beam line at the European Synchrotron Radiation Facility (ESRF, Grenoble, France). All the three data sets were indexed and processed using HKL-2000 package [@bib16]. The summary of data collection statistics is given in [Table 1](#t0005){ref-type="table"}.Table1Data collection and refinement statistics.Table1**ParameterCYSCYTCDP**PDB ID4ZT85CSO5CSTSpace groupH3H3H3Unit cell dimensions (Å)*a*=*b*130.3130.2130.2*c*39.939.940.5Number of molecules in unit cell999Resolution range (Å)37.63--1.9837.62--1.7838.11--1.78Total number of observed reflections83496149580132103Number of unique reflections166712297922958Overall completeness of data (%)99.9(99.8)99.9(99.5)99.8(96.9)Overall *R*~sym~[a](#tbl1fna){ref-type="table-fn"} (%)7.3(28.3)5.0(27.2)6.5(49.2)Overall *I*/*σ* (I)32.3(4.2)51.2(4.8)34.0(2.6)*R*~cryst~[b](#tbl1fnb){ref-type="table-fn"} (%)17.918.515.5*R*~free~ (%)20.421.418.9Protein atoms191119111911Ligand atoms (one molecule)8 (CYS)17(CYT)25 (CDP)Carbohydrate atoms (NAG)141414Water molecules220246245R.m.s.d in bond lengths (Å)0.010.010.02R.m.s.d in bond angles (deg)1.081.092.0R.m.s.d in dihedral angles (deg)13.112.412.3Overall *G* factor0.140.15−0.02Wilson B-factor (Å^2^)24.123.921.8Mean B-factor for main chain atoms28.728.225.7Mean B-factor for side chain atoms and water oxygen atoms32.533.433.1Mean B-factor for all atoms30.831.129.7Residues in the most favored regions (%)93.292.793.2Residues in the additionally allowed regions (%)6.46.86.4Residues in the disallowed regions (%) (Leu 77 as part of type II′ β-turn)0.50.50.5.0.2[^2][^3][^4]

2.6. Structure determination and refinement {#s0040}
-------------------------------------------

The structures of the complexes of *Mb*RIP1 with CYS ([Fig. 3](#f0015){ref-type="fig"}A), CYT ([Fig. 4](#f0020){ref-type="fig"}A) and CDP ([Fig. 5](#f0025){ref-type="fig"}A) were determined with molecular replacement method [@bib17] using coordinates of native protein as the model (PDB: 3S9Q) [@bib13]. It gave the clear solutions. All the three structures were refined with REFMAC 5 [@bib18] from the CCP4i Version 4.2 program package [@bib19], [@bib20] for 25 cycles. After these cycles of refinement, the *R*~cryst~/*R*~free~ factors for the three complexes reduced to values of 0.251/0.282, 0.241/0.281 and 0.261/0.283, respectively. The models were improved by manual model building with programs O [@bib21] and Coot [@bib22] on the graphics workstations. The difference (*F*~o~−*F*~c~) Fourier maps calculated at this stage revealed extra densities at the substrate binding site in *Mb*RIP1 into which molecules of CYS ([Fig. 3](#f0015){ref-type="fig"}B), CYT ([Fig. 4](#f0020){ref-type="fig"}B) and CDP ([Fig. 5](#f0025){ref-type="fig"}B) were fitted. These non-protein electron densities were observed at higher than 2.5*σ*. Out of these three compounds, the terminal phosphate of CDP is found in two conformations and is therefore modeled likewise as shown in [Fig. 5](#f0025){ref-type="fig"}B. The atoms of these compounds were included in the subsequent cycles of refinements. The same difference (*F*~o~−*F*~c~) Fourier maps were also used for locating the positions of water oxygen atoms. The positions of water oxygen atoms were picked up based on the isolated electron densities at more than 2.5*σ* and having spherical shapes with distances up to 3.5 Å from nitrogen and oxygen atoms of protein. This gave 220, 246, and 245 water oxygen atom positions for the complexes with (i) CYS, (ii) CYT, and (iii) CDP respectively. After including all these atoms in the further cycles, the refinement converged to value of 0.179/0.204, 0.185/0.214 and 0.155/0.189 for *R*~cryst~/*R*~free~ factors for structures (i) to (iii) respectively. The final refinement statistics for all the three structures are included in [Table 1](#t0005){ref-type="table"}. The refined atomic coordinates have been deposited in the Protein Data Bank (PDB) with accession codes of 4ZT8, 5CSO and 5CST, respectively.Fig. 3(A) Schematic numbering of atoms in Cytosine, (B) the OMIT (*F*~o~−*F*~c~) (blue) electron density for cytosine at 3.0*σ* level, (C) hydrogen bonds between *Mb*RIP1 and cytosine are shown by dotted lines, (D) the ribbon diagram of *Mb*RIP1 with cytosine in the substrate binding cleft and (E) a grasp representation of the substrate binding cleft with cytosine in the cleft (ball and stick model). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 3Fig. 4(A) Schematic numbering of atoms in Cytidine, (B) the OMIT (*F*~o~−*F*~c~) (blue) electron density for cytidine at 2.5*σ* level, (C) hydrogen bonds between protein and cytidine atoms are shown with dotted lines, (D) the ribbon diagram of the protein with bound cytidine in the substrate binding cleft and (E) a grasp representation of the cleft with cytidine placed in the cleft. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 4Fig. 5(A) Schematic numbering of atoms in Cytidine diphosphate, (B) the OMIT (*F*~o~−*F*~c~) (blue) electron density for cytidine diphosphate at 2.5*σ* level, (C) hydrogen bonds between protein and cytidine diphosphate atoms are indicated by dotted lines, (D) the ribbon diagram for *Mb*RIP1 with cytidine diphosphate in the substrate binding site and (E) a grasp representation of the substrate binding cleft with cytidine diphosphate (in ball and stick representation) bound to it. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 5

3. Results {#s0045}
==========

3.1. Analysis of binding studies using fluorescence spectroscopy {#s0050}
----------------------------------------------------------------

In order to determine the binding affinities of three ligands (i) CYS, (ii) CYT and (iii) CDP, the fluorescence properties of the binding site in *Mb*RIP1 were exploited. The intrinsic fluorescence of *Mb*RIP1 when excited at 280 nm is due to the presence of Tyr70 and Tyr111 in the substrate binding site. The fluorescence spectra were recorded in the presence of increasing amounts of ligands. The fluorescence intensities of *Mb*RIP1 decreased gradually when the concentrations of ligands were increased, although the positions of emission maxima as well the shapes of the peaks remained unaltered. This suggested that the binding of ligands to *Mb*RIP1 did not alter the environment in the vicinity of two aromatic residues. The observed fluorescence data were used for calculating the fluorescence quenching defined as *Q*%=(*F*~o~−*F*)/*F*~o,~ where *F* is the fluorescence intensity measured after the ligands were added to the solution of *Mb*RIP1 while *F*~o~ is the fluorescence intensity in the absence of ligands. Plots of graphs of *Q* (%) against the molar ratios of ligands to protein are shown in [Fig. 1](#f0005){ref-type="fig"}. The least-squares fits of the fluorescence intensity changes for the ligand/protein binding curves were obtained by Sigma Plot 8.0 [@bib23]. The error bars on the experimental points were estimated from the average of values that were calculated using the binding equation described by Scatchard [@bib24]. The approximate value of the dissociation constants (*K*~D~) for the binding of (i) CYS, (ii) CYT and (iii) CDP were found to be 2.3×10^−4^ M, 5.0×10^−6^ M, and 2.8×10^−7^ M, respectively. These results indicated that all the three ligands bound to *Mb*RIP1 with significant affinities.

3.2. Determination of binding affinity using SPR {#s0055}
------------------------------------------------

The molecular interactions between *Mb*RIP1 and its binding partners CYS, CYT and CDP, were studied in real time using SPR spectroscopy. The sensograms for the interactions with (i) CYS, (ii) CYT and (iii) CDP were shown in [Fig. 2](#f0010){ref-type="fig"}. The increase of resonance units (RU) from the baseline represents the binding of ligands to the immobilized protein. The plateau line represents the steady state equilibrium phase of interactions between protein and the ligands whereas the decrease in RU from the plateau represents the dissociation phase. The values of dissociation constants (*K*~D~) were calculated to be 4.1×10^−5^ M, 9.4×10^−7^ M and 1.1×10^−7^ M for the binding of CYS, CYT and CDP respectively.

3.3. X-ray structural studies {#s0060}
-----------------------------

### 3.3.1. Structure of the complex of MbRIP1 with cytosine {#s0065}

The structure of the complex of *Mb*RIP1 with cytosine was determined at 1.98 Å resolution with 93.2% residues in the most favored regions of the Ramachandran map [@bib25] as calculated using PROCHECK [@bib26]. It may be mentioned here that the substrate binding site in the native structure contains ten water molecules which are interlinked through hydrogen bonds \[16, PDB ID: 3S9Q\]. Upon binding of cytosine, four out of ten water molecules were dislodged from the substrate binding site. The structure showed that cytosine formed five hydrogen bonds ([Fig. 3](#f0015){ref-type="fig"}C). The residues that formed direct hydrogen bonds with cytosine included Val69, Gly109 and Arg163 while Tyr111 interacted through a solvent water molecule. Cytosine also formed several van der Waals contacts with residues, Tyr70, Leu151 and Ile 155. The position of CYS in the substrate binding cleft is shown in [Fig. 3](#f0015){ref-type="fig"}D. It is clearly seen that cytosine is completely buried in the substrate binding pocket ([Fig. 3](#f0015){ref-type="fig"}E) with a buried surface area of 157 Å^2^ as calculated using PISA server [@bib21]. However, a significant space in the pocket was still unoccupied. The conformations as defined by torsion angles, χ^1^ and χ^2^ for the side chains of two important residues, Tyr70 andTyr111 of the substrate binding site were estimated to be -70^◦^ and 158^◦^, and −81° and 140°, respectively.

### 3.3.2. Structure of the complex of MbRIP1 with cytidine {#s0070}

The structure of the complex of *Mb*RIP1 with cytidine was determined at 1.78 Å resolution. As calculated using PROCHECK [@bib26], it showed that the 92.7% residues were present in the most favored regions of the Ramachandran map [@bib25]. Upon the binding of cytidine to *Mb*RIP1, five out of ten water molecules were dislodged from the substrate binding site. The structure of the complex showed that the ligand is stabilized by nine hydrogen bonds ([Fig. 4](#f0020){ref-type="fig"}C). The residues that form hydrogen bonds include Ile71, Glu85, Tyr111, Glu160 and Arg163. Several van der Waals interactions have also been observed. The notable van der Waals contacts were formed with residues, Tyr70, Tyr111, Asn110 and Gly109. The orientation of cytidine in the substrate binding cleft can be seen in [Fig. 4](#f0020){ref-type="fig"}D. The cytidine molecule is fully buried in the cleft ([Fig. 4](#f0020){ref-type="fig"}E) with a buried surface area of 254.2 Å^2^. In this case**,** the conformations of the side chains of Tyr70 and Tyr111 as defined by torsion angles, *χ*^1^ and *χ*^2^ were found to be −81° and −172°, and −83° and 141°, respectively.

### 3.3.3. Structure of the complex of MbRIP1 with cytidine diphosphate {#s0075}

The structure of the complex of *Mb*RIP1 with cytidine diphosphate (CDP) was determined at 1.78 Å resolution. As calculated using PROCHECK [@bib26], the refined model has 93.2% of amino acid residues in the most favored regions of Ramachandran map [@bib25]. Upon binding of CDP to *Mb*RIP1, seven out of ten water molecules were dislodged. The map indicates that the beta phosphate has two conformations. The structure of the complex showed that CDP formed at least 14 hydrogen bonds ([Fig. 5](#f0025){ref-type="fig"}C). It also formed several van der Waals contacts involving residues, Tyr70, Ile71, Tyr111, Asn110, Phe83, Gly109 and Glu112. The orientation of CDP in the substrate binding site can be seen from [Fig. 5](#f0025){ref-type="fig"}D. CDP is fitted well in the substrate binding cleft ([Fig. 5](#f0025){ref-type="fig"}E) with a buried surface area of 293.5 Å^2^. In this case**,** the conformations of the side chains of Tyr70 and Tyr111 as defined by torsion angles, *χ*^1^ and *χ*^2^ were found to be −77° and −162°, and −77° and 135°, respectively.

4. Discussion {#s0080}
=============

The rectangular substrate binding cleft in type 1 RIPs is situated between two domains. The amino acid residues that constitute the substrate binding cleft include Tyr70, Tyr111, Glu85, Ile155, Ala87, Asn110, Ile186, Glu160, Glu112, Asn68 and Arg163. In the native structure of *Mb*RIP1 (PDB ID: 3S9Q), ten water molecules, W1 to W10 were observed in the substrate binding cleft which were interconnected through hydrogen bonds ([Fig. 6](#f0030){ref-type="fig"}A). Upon binding to cytosine, four water molecules, W2, W3, W4 and W7 were dislodged from the cleft ([Fig. 6](#f0030){ref-type="fig"}B) while the binding of cytidine removed five water molecules, W1, W2, W4, W5 and W7 ([Fig. 6](#f0030){ref-type="fig"}C). When cytidine diphosphate bound to *Mb*RIP1, seven water molecules, W1, W2, W4, W5, W6, W7 and W10 were dislodged ([Fig. 6](#f0030){ref-type="fig"}D). This showed that three water molecules, W2, W4 and W7 were dislodged in all the structures indicating that it was a common subsite occupied by some parts of these compounds. The two water molecules, W8 and W9 remained present in all the structures indicating that these two locations were never occupied by these compounds. In the case of cytosine, two water molecules, W1 and W5 remained bound to protein while W3 was removed. In contrast, in both other structures, W1 and W5 were never observed while W3 was present. This indicated that the positioning of cytosine in the substrate binding cleft was slightly different from those occupied by other compounds. The molecule of cytidine diphosphate occupies the whole substrate binding site in *Mb*RIP1 and thus suggests that the optimum size for fitting the compound in the substrate binding site corresponds to cytidine diphosphate.Fig. 6(A) Ten water molecules, W1 (526), W2 (525), W3 (524), W4 (272), W5 (520), W6 (453), W7 (263), W8 (427), W9 (390), W10 (273) were observed in the substrate binding cleft of the native unliganded structure of *Mb*RIP1 (PDB ID: 3S9Q). The numbers in parentheses correspond to numbers in the PDB. (B) The binding of cytosine to *Mb*RIP1 replaced four water molecules, W2, W3, W4 and W7. (C) The binding of cytidine replaced five water molecules, W1, W2, W4, W5 and W7. (D) Upon binding of cytidine diphosphate seven water molecules, W1, W2, W4, W5, W6, W7 and W10 were removed from the substrate binding site.Fig. 6

The type 1 RIPs are known to remove an adenine residue from the sarcin/ricin loop (SRL) of rRNA in eukaryotic ribosomes [@bib2], [@bib3]. The structural studies have also shown that whenever adenine containing nucleosides and nucleotides were used for crystallization of the complexes with *Mb*RIP1, invariably, the complexes with adenine were obtained as these used to get hydrolyzed. It has also been shown that *Mb*RIP1 binds to mRNA 5\'cap structures with m^7^GpppN where N is any base [@bib12]. The present structures showed that *Mb*RIP1 can also bind to cytosine and cytosine containing nucleoside and nucleotide. It is observed that cytosine, cytidine and CDP were fully buried in the cleft. It suggested that the optimum element for specificity in cytosine containing sequences of RNA structures is a nucleoside moiety. The number of interactions observed with CDP were maximum indicating that it has the maximum binding affinity.

One of the main differences in the structure of protein upon binding of cytosine and cytosine containing compounds to *Mb*RIP1 as compared to those of adenine and guanine pertains to the conformation of the side chain of Tyr70. The values of the torsion angles, *χ*^1^ and *χ*^2^ for the side chain of Tyr70 in the complexes of cytidine and cytidine diphosphate were found centered at −70° and −165°, respectively. The corresponding values in the complexes of *Mb*RIP1 with adenine and guanine were found to be centered at −90° and −75°, respectively. The corresponding values in the unbound native structure were found to be −66° and 165°, respectively. Clearly, in the three structural states, the conformations of the side chain of Tyr70 are very different ([Fig. 7](#f0035){ref-type="fig"}). It may be mentioned that the conformation of the side chain of Tyr111 remains the same in all the three states ([Fig. 7](#f0035){ref-type="fig"}). The orientation of the plane of the aromatic ring of cytosine with respect to that of the aromatic ring of Tyr70 was 130° while the corresponding angle in the complexes with adenine and guanine were centered at 165°. The plane of adenine ring in the cleft is oriented nearly parallel to the plane of the side chain of Tyr70 while that of cytosine is deviated considerably from parallel orientation. This difference is important for the catalytic activity of *Mb*RIP1. These differences may be responsible for the removal of adenine from the SRL of rRNA while cytosine cannot be removed because of different orientation in the cleft. However, it may act as an inhibitor of RIPs.Fig. 7Showing the orientations of the planes of aromatic rings of five ligands with respect to the planes of Tyr70 and Tyr111 in the complexes of *Mb*RIP1 with cytosine (green), cytidine (orange), cytidine diphosphate (yellow), adenine (grey) and guanine (cyan). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 7
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[^2]: The values in parentheses correspond to the values in the highest resolution shell.

[^3]: *R*~sym~=∑~hkl~∑~i~\|*I*~i~(*hkl*)−\<*I*(*hkl*)\>\|/∑~hkl~∑~i~*I*~i~(*hkl*) where *I*~i~ (*hkl*) is the intensity of the *i*th measurement of reflection *hkl* and \<*I*(*hkl*)\>is the mean value of *I*~i~ (*hkl*) for all *i* measurements.

[^4]: *R*~cryst=~∑~hkl~\|(*F*~obs~)−(*F*~cal~)\|/∑~hkl~\|(*F*~obs~)\| where *F*~obs~ is the observed structure factor amplitude and *F*~cal~ is the structure amplitude calculated from the model. *R*~free~ is the same as *R*~cryst~ except that it has been calculated with a 5% data that were excluded from the refinement calculations.
